CRO Cameron Brooks sold 1,242 shares of AXON at $500.00 ($621.0K) under 10b5-1 plan; stock down -46.8% from 52-week high.
Cameron Brooks (Chief Revenue Officer) executed a scheduled sale of 1,242 shares at $500.00 on 2026-06-04 under a 10b5-1 trading plan adopted on 2025-12-08, reducing holdings by 2.4% to 49.7K shares. The sale occurred at $500.00 while the current price stands at $471.06, representing a -46.8% decline from the 52-week high of $885.92. His prior sales at AXON show mixed outcomes: a March 2026 sale preceded a -30.8% 30-day decline, while a May 2025 sale preceded a +10.5% 30-day gain. As a scheduled transaction, this sale carries no discretionary timing signal; its significance lies primarily in the substantial valuation erosion from recent highs and the executive's residual stake of 49.7K shares in a $38.0B market-cap company with strong fundamentals (33.5% annual revenue growth, $169.3M net income).